1. Xinyuan Technology: in the second quarter of 2021, the company's total operating income of 129 million, an increase of 56.57% year-on-year; gross profit of 39.7 million, net profit of 6.304 million yuan. Disclosed in March 20, the company's research and development of Yuanbao infrared temperature measurement robot, is now actively on the city and application scenarios for landing and promotion, do our best to help epidemic prevention and control.
2. Myriad Medical: In the first quarter of 2021, the company's total operating income of 5.781 billion, an increase of 21.93% year-on-year; gross profit of 3.699 billion, net profit of 1.696 billion yuan. 20 March, the company has received overseas, including Asia-Pacific, Europe, the Middle East, and other regions in response to the outbreak of the procurement needs of the recent epidemic due to the rapid rise of the epidemic in Italy. The Italian government urgently purchased nearly 10,000 units of anti-epidemic equipment from Myriad, including products such as monitors and ventilators.
3. Spotlight Technology: 2020 earnings per share of 1.1000 yuan, net profit of 489 million yuan, an increase of 1128.82% over last year. 21 February 2020 the company said in the interactive platform, CDC around the world is a subsidiary of the company's customers Jitian Instruments, the main products are atomic fluorescence photometer and flow injection analyzer, there are products put into the Hubei, Yunnan region The company's main products are atomic fluorescence photometer and mobile injection analyzer, and some products are put into the Hubei and Yunnan areas.
4. Inventec Medical: The main attribute is the concept of anti-epidemic stocks. In the United States, the company is a leading manufacturer of disposable medical consumables and medical durable equipment in China. The main business covers medical protection, rehabilitation care, health care physiotherapy, examination consumables and other segments, strategically positioned in the production of high-end disposable PVC gloves, nitrile gloves (medical-grade gloves), is one of the very few companies in China to be able to a high proportion of sustained and stable production of medical-grade gloves. 2020, the demand for disposable medical gloves in the context of global epidemics, the demand for the explosive growth.
5. New National Vein: 2021 Q2 quarterly report shows that the new National Vein realized revenue of 1.015 billion yuan, up 12.25%; gross profit of -2.666 million yuan, net profit of -116 million yuan. The new crown epidemic has had a significant impact on the production and operation of the company's hotels, business travel and other related businesses, and the company continues to increase investment in 5G development and operation and other new business expansion in accordance with the established strategy, as well as the gradual withdrawal or transformation of traditional businesses.